Latest Breaking News On - Nanatinostat vrx - Page 1 : vimarsana.com

Viracta Therapeutics Announces First Patient Dosed in Phase 1b/2 Trial of Nana-val in Patients with Advanced Epstein-Barr Virus-Positive Solid Tumors

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced that the first.

Nanatinostat vrxLisa rojkjaerAshleigh barretoViracta therapeutics incViracta therapeuticsChief medical officerAssociated cancersPrivate securities litigation reform actRelations contactInvestor relations

Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral Combination of Nanatinostat and Valganciclovir (Nana-val) for the Treatment of Epstein Barr Virus-Positive Diffuse Large B-cell Lymphoma

SAN DIEGO, Nov. 29, 2021 /PRNewswire/ Viracta Therapeutics, Inc. , a precision oncology company targeting virus-associated malignancies, today announced that the U.S. Food and Drug. | November 29, 2021

Nanatinostat vrxIvor roystonEpstein barrAshleigh barretoDrug administrationViracta therapeutics incViracta therapeuticsChief executive officerDrug evaluationAssociated cancersEpstein barr virusPrivate securities litigation reform actRelations contactInvestor relationsNc stock exchangePress release

Viracta Therapeutics Initiates Phase 1b/2 Trial in Epstein-Barr Virus-Positive (EBV+) Solid Tumors

/PRNewswire/ Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, today announced the initiation.

Nanatinostat vrxLisa rojkjaerDan chevallardJoyce allaireViracta therapeutics incViracta therapeuticsChief medical officerPrivate securities litigation reform actRelations contactOperating officerChief financial

Viracta Therapeutics Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates

Viracta Therapeutics Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Updates
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Ivor roystonAyman elguindyKristen cunananJoyce allaireBiljana nadjsombatiNanatinostat vrxDan chevallardKols pierluigi porcuCompany contactMd thomas jefferson universitySunesis pharmaceuticalsDepartment of pathologyYale university school of medicineDepartment of pediatricsViracta therapeutics incPhd stanford medicine quantitative sciences unit